Increasing highly active antiretroviral therapy (HAART) treatment for people with HIV/AIDS will provide significant cost savings over a relatively short period of time, according to a formal economic analysis led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at Providence Health Care and the University of British Columbia (UBC).
- HIV prevention strategy key to curbing epidemic and cutting long-term treatment costsWed, 7 Jul 2010, 13:23:58 EDT
- High antiretroviral therapy adherence associated with lower health care costsWed, 6 Jan 2010, 12:10:18 EST
- Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costsMon, 7 Jun 2010, 19:01:07 EDT
- HIV/AIDS treatment curbs spread of disease: UBC-BC CfE studyMon, 19 Jul 2010, 15:50:56 EDT
- Cost of prostate cancer care varies with initial treatment choiceMon, 23 Aug 2010, 1:29:09 EDT